NASDAQ
Heron Therapeutics, Inc. (HRTX) has a current ratio of 2.48x as of Monday, May 25, 2026. This represents a 7.64% decrease compared to its 12-month average of 2.68x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.